Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Canatu receives 1-2 MEUR order for inspection membranes from existing semiconductor sector customer

By Atte RiikolaAnalyst
Canatu

Translation: Original published in Finnish on 6/5/2025 at 8:02 am EEST.

On Wednesday, Canatu announced that it had received a purchase order from an existing semiconductor industry customer to supply inspection membranes used in EUV mask inspection. The use of these membranes reduces damage to EUV optics and enhances quality control during EUV mask inspection.

The value of the purchase order is classified within the lowest quartile of the “medium” category (1.0–5.0 MEUR) outlined in Canatu’s disclosure policy.  Its size is therefore in the range of 1-2 MEUR. Revenue from the order will be fully recognized in the 2025 financial year and will therefore contribute to the revenue we have forecasted for this year (2025e: 22.8 MEUR). In our forecast, we have anticipated that of the semiconductor sector's revenue (2025e: 19.8 MEUR), just over 8 MEUR would come from the reactor business and the rest would come from inspection membranes and other revenue items.

Back in April, Canatu announced a multi-million euro joint development agreement with DENSO related to the automotive industry, and in May the company also received a small order from a customer in the defense sector. However, the growth outlook for the current year depends particularly on potential new reactor orders, which we wrote more about in our post-H2 result update.

Canatu

9.48EUR2025-06-04 18:00
13EURTarget price
Accumulate
Recommendation updated:30/03

Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.

Read more on company page

Key Estimate Figures30/03

202425e26e
Revenue22.022.835.4
growth-%62.1 %3.7 %55.1 %
EBIT (adj.)-4.8-7.5-4.0
EBIT-% (adj.)-21.9 %-32.8 %-11.4 %
EPS (adj.)-0.01-0.11-0.07
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.